MEGAN DEEL: Open Payments
NPI 1538790092 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 15 payments from 8 companies in 2025. Trend: 2023 $137 · 2024 $197 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 4 | $67 |
| Astellas Pharma US Inc | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
| Amgen Inc. | 2 | $32 |
| Organon LLC | 1 | $29 |
| Boston Scientific Corporation | 1 | $23 |
| Exeltis, USA Inc. | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: ZURZUVAE, Veozah, Mirena, EVENITY, JADA SYSTEM, General - Female SUI, SLYND, Wegovy.
Industry payments across VA — which companies pay providers there.
